The Russian MoH approved 158 new clinical trials of all types
including local and bioequivalence studies during Q3 2017,
demonstrating a 34% decrease in comparison with the same period
last year. Igor Stefanov at Synergy Research Group compares how
clinical trials in Russia have changed between 2016 and 2017.